Holdings
Live Oak Health Sciences Fund
As of Jul 31, 2026, Live Oak Health Sciences Fund reported 26 positions worth US$54.6M. Largest: Cardinal Health, Inc., Jazz Pharmaceuticals Plc and United Therapeutics Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cardinal Health, Inc. | 14,297 | US$3.29M | no change | Jul 31, 2026 |
| Jazz Pharmaceuticals Plc | 12,812 | US$3.24M | no change | Jul 31, 2026 |
| United Therapeutics Corporation | 5,543 | US$2.87M | no change | Jul 31, 2026 |
| Exelixis, Inc. | 52,445 | US$2.78M | no change | Jul 31, 2026 |
| Amgen Inc. | 7,077 | US$2.73M | no change | Jul 31, 2026 |
| Lantheus Holdings, Inc. | 26,355 | US$2.63M | no change | Jul 31, 2026 |
| Novartis Ag | 16,819 | US$2.62M | −67 | Jul 31, 2026 |
| Mckesson Corporation | 2,973 | US$2.55M | no change | Jul 31, 2026 |
| Cencora, Inc. | 8,034 | US$2.5M | no change | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. | 3,260 | US$2.49M | no change | Jul 31, 2026 |